Bainan Biotech ApS: Financial statements 2020
CVR: 39904276
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Bainan Biotech ApS (CVR 39904276) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,952,827 and a net result of DKK -509,902. Equity in the 2020 report amounted to DKK -351,061. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,952,827
- Profit/Loss
- DKK -509,902
- Equity
- DKK -351,061
- Total Assets
- DKK 13,555,194
- Employees
- 1
Official annual report
How creditworthy is Bainan Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 1, 2020, Arvind Mansha Hundal has joined the board of directors of Bainan Biotech ApS.
As of November 15, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of Bainan Biotech ApS.
As of November 15, 2020, Mette Marie Rosenkilde is registered as chairman of Bainan Biotech ApS.
As of November 14, 2020, Mette Marie Rosenkilde has left the board of directors of Bainan Biotech ApS.
Bainan Biotech ApS has published its interim report for the period September 27, 2018 – December 31, 2019.
About Bainan Biotech ApS
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company has been dissolved on 20 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743.